Nolato ABNN

Nolato AB

5.27USDD
+0.27+5.41%
At close at Oct 31, 2024, 13:07 GMT
USD
No trades
See on Supercharts

NLTBF fundamentals

Key facts

Market capitalization‪1.42 B‬USD
Founded1961
CEOChrister Wahlquist
Websitenolato.se
About

Nolato AB engages in the development and manufacture of polymer product systems for customers in medical technology, telecommunications, hygiene, automotive products and other selected industrial sectors. It operates through the following segments: Medical Solutions, Integrated Solutions, and Industrial Solutions. The Medical Solutions segment develops and manufactures complex product systems and components within medical technology, as well as advanced packaging solutions for pharmaceuticals and dietary supplements. The Integrated Solutions segment caters to two sectors, namely consumer electronics, and electromagnetic compatibility and thermal. The Industrial Solutions segment focuses on components and product systems for customers in the automotive industry, hygiene, packaging, gardening and forestry, domestic appliances and other selected industrial segments. The company was founded in 1938 and is headquartered in Torekov, Sweden.

Ownership
‪‪241.78 M‬‬
Free Float shares
‪‪191.86 M‬‬ (79.35%)
Closely held shares
‪‪49.93 M‬‬ (20.65%)
Free Float shares
‪‪191.86 M‬‬ (79.35%)
Closely held shares
‪‪49.93 M‬‬ (20.65%)
Capital structure
Market cap
‪‪1.42 B‬‬
Debt
‪‪139.68 M‬‬
Cash & equivalents
‪‪60.48 M‬‬
Enterprise value
‪‪1.50 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪1.42 B‬‬
Price to earning ratio (P/E)
20.80x
Price to sales ratio (P/S)
1.42x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
20.80x
Price to sales ratio (P/S)
1.42x
Valuation ratios
‪0.00‬
‪0.45‬
‪0.90‬
‪1.35‬
‪1.80‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪9.00‬
‪18.00‬
‪27.00‬
‪36.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪3%‬
‪4%‬
‪5%‬
‪6%‬
‪7%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪60.00 M‬‬
‪‪120.00 M‬‬
‪‪180.00 M‬‬
‪‪240.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪60.00 M‬‬
‪‪120.00 M‬‬
‪‪180.00 M‬‬
‪‪240.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪60.00 M‬‬
‪‪120.00 M‬‬
‪‪180.00 M‬‬
‪‪240.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Medical Solutions
Industrial Solutions
Integrated Solutions
By country
Period: 2024
Rest of Europe
North America
Sweden
Asia
Other Nordic Countries
Rest of the World

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬
‪‪210.00 M‬‬
‪‪280.00 M‬‬
Actual
Estimate
Earnings
Next:May 6, 2025
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪0.02‬
‪0.04‬
‪0.06‬
‪0.08‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
61.41%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
2.52%
Next payment
0.147
Next ex-date
May 7, 2025
Dividend history
‪1.5%‬
‪2.0%‬
‪2.5%‬
‪3.0%‬
‪3.5%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.06‬
‪0.12‬
‪0.18‬
‪0.24‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪50.00 M‬‬
‪‪100.00 M‬‬
‪‪150.00 M‬‬
‪‪200.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪150.00 M‬‬
‪‪300.00 M‬‬
‪‪450.00 M‬‬
‪‪600.00 M‬‬
Assets
Liabilities